Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.6739
-0.0271 (-3.87%)
At close: May 12, 2025, 4:00 PM
0.6844
+0.0105 (1.56%)
After-hours: May 12, 2025, 4:30 PM EDT
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 103 employees as of December 31, 2024. The number of employees decreased by 182 or -63.86% compared to the previous year.
Employees
103
Change (1Y)
-182
Growth (1Y)
-63.86%
Revenue / Employee
$301,757
Profits / Employee
-$1,945,660
Market Cap
243.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LXRX News
- 6 days ago - Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 6 days ago - Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 17 days ago - Top 2 Health Care Stocks That May Crash This Month - Benzinga
- 5 weeks ago - Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Lexicon Pharmaceuticals Shares Soar on Novo Nordisk Licensing Deal - Market Watch
- 6 weeks ago - Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk - Benzinga
- 6 weeks ago - Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851 - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025 - GlobeNewsWire